PET-CT Identifies Cognitive Reserve in Early-Onset Alzheimer's Disease
By MedImaging International staff writers
Posted on 19 May 2011
New findings have revealed that the "cognitive reserve" in early-onset Alzheimer's disease (AD) and positron emission tomography-computed tomography (PET-CT) imaging can be employed to effectively to identify early-onset AD patients. Posted on 19 May 2011
"Although early-onset Alzheimer's dementia is quite rare, it can be devastating to the patients that carry the diagnosis," remarked Dr. Jacob Richard Hodge, lead researcher for this study from the Mayo Clinic (Rochester, MN, USA). "Symptoms are often unexpected and support networks are generally directed towards an older population."
In patients presenting with similar clinical severities of the disease, researchers found a cognitive reserve, which slowed the outward expression of symptoms. "Our research demonstrates that those patients with increasing education are better able to cope with the disease pathology before they express the symptoms of Alzheimer's dementia," Dr. Hodge said. This study evaluated PET-CT scans in 91 patients under age 65 to see if this cognitive reserve could be identified with early-onset AD, which often has a more aggressive course and progression.
Moreover, researchers replicated previously published data using PET-CT examinations, and they were able to detect significant abnormalities in patients with early-onset AD, thus validating its usefulness with younger patients. "Alzheimer's dementia is often not suspected in younger patients," Dr. Hodge said. "Therefore, PET-CT brain imaging can be helpful in the diagnosis."
Whereas the discovery of the cognitive reserve will not slow the progression of the disease, Dr. Hodge is confident that patients can improve the quality of their lives with the proper diagnosis and education. "Once the diagnosis is determined, a patient can begin to manage the disease and plan for the future," Dr. Hodge stated.
Dr. Hodge presented the findings of this study May 2, 2011, at the 2011 American Roentgen Ray Society (ARRS) annual meeting in Chicago (IL, USA).
Related Links:
Mayo Clinic